Patents by Inventor Joshua A. Boger

Joshua A. Boger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • QUINAZOLINES USEFUL AS MODULATORS OF ION CHANNELS
    Publication number: 20100249100
    Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels and calcium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    Type: Application
    Filed: March 29, 2010
    Publication date: September 30, 2010
    Applicant: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Dean Wilson, Lev Fanning, Paul Krenitsky, Joshua Boger
  • Quinazolines useful as modulators of ion channels
    Patent number: 7718658
    Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels and calcium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    Type: Grant
    Filed: August 31, 2005
    Date of Patent: May 18, 2010
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Dean Wilson, Lev Fanning, Paul Krenitsky, Joshua Boger
  • Quinazolines useful as modulators of ion channels
    Publication number: 20060154935
    Abstract: The present invention relates to compounds useful as inhibitors of voltage-gated sodium channels and calcium channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.
    Type: Application
    Filed: August 31, 2005
    Publication date: July 13, 2006
    Inventors: Dean Wilson, Lev Fanning, Paul Krenitsky, Joshua Boger
  • Renin inhibitors containing a C-terminal amide cycle
    Patent number: 4485099
    Abstract: Renin inhibitory peptides of the formula ##STR1## and analogs thereof inhibit renin and are useful for treating various forms of renin-associated hypertension and hyperaldosteronism.
    Type: Grant
    Filed: June 15, 1983
    Date of Patent: November 27, 1984
    Assignee: Merck & Co., Inc.
    Inventors: Joshua A. Boger, Daniel F. Veber